Hereditary Breast Cancer
Management
Recommendation 1.1
Recommendation 1.2
Recommendation 1.3
Recommendation 1.4
Recommendation 2.1
Recommendation 2.2
Recommendation 2.3
Recommendation 2.4
Recommendation 3.1
Recommendation 3.2
Recommendation 4.1
Recommendation 4.2
Recommendation 5.1
Recommendation 5.2
Recommendation 6.1
Recommendation 6.2
Recommendation 6.3
Recommendation 7
Recommendation 8
Recommendation 9.1
Recommendation 9.2
Recommendation 10
Recommendation Grading
Disclaimer
Overview
Title
Management of Hereditary Breast Cancer
Authoring Organizations
American Society for Radiation Oncology
American Society of Clinical Oncology
Society of Surgical Oncology
Publication Month/Year
April 3, 2020
Last Updated Month/Year
April 13, 2023
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Target Patient Population
Women with hereditary breast cancer with germline mutations, advanced or early stage
Target Provider Population
Medical oncologists, radiation oncologists, surgical oncologists, oncology nurses, patients/caregivers
Inclusion Criteria
Female, Adolescent, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room, Outpatient, Radiology services
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Management
Diseases/Conditions (MeSH)
D061325 - Hereditary Breast and Ovarian Cancer Syndrome
Keywords
breast cancer, Hereditary Breast Cancer, Hereditary Cancer, PARP Inhibitors, germline mutations, Breast Cancer
Source Citation
DOI: 10.1200/JCO.20.00299 Journal of Clinical Oncology